(Q71032606)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8612379%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

title

Diltiazem enhances the effects of triazolam by inhibiting its metabolism (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8612379%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

author name string

A Varhe

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8612379%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

K T Olkkola

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8612379%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

P J Neuvonen

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8612379%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

publication date

1 April 1996

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8612379%20AND%20SRC:MED&resulttype=core&format=json

Clinical Pharmacology & Therapeutics

15 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8612379%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

volume

59

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8612379%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

page(s)

369-375

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8612379%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8612379%20AND%20SRC:MED&resulttype=core&format=json

Inhibition of hepatic microsomal drug metabolism by the calcium channel blockers diltiazem and verapamil.

15 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990103-4

Diltiazem treatment impairs hepatic drug oxidation: studies of antipyrine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990103-4

Pharmacokinetic Interactions with Calcium Channel Antagonists (Part I)1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990103-4

Pharmacokinetic Interactions with Calcium Channel Antagonists (Part II)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990103-4

Dose of midazolam should be reduced during diltiazem and verapamil treatments

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990103-4

Simultaneous determination of midazolam and its three hydroxy metabolites in human plasma by electron-capture gas chromatography without derivatization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990103-4

Simultaneous screening and quantitation of alpidem, zolpidem, buspirone and benzodiazepines by dual-channel gas chromatography using electron-capture and nitrogen-phosphorus detection after solid-phase extraction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990103-4

High-performance liquid chromatographic determination of diltiazem and four of its metabolites in plasma: evaluation of their stability

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990103-4

Oral triazolam is potentially hazardous to patients receiving systemic antimycotics ketoconazole or itraconazole

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990103-4

7 January 2021

Metabolic polymorphisms

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990103-4

Effect of age and gender on the activity of human hepatic CYP3A

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990103-4

Inhibition of desipramine 2-hydroxylation by quinidine and quinine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990103-4

Plasma concentrations of triazolam are increased by concomitant ingestion of grapefruit juice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990103-4

Triazolam in cirrhosis: pharmacokinetics and pharmacodynamics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990103-4

Changes in antipyrine and indocyanine green kinetics during nifedipine, verapamil, and diltiazem therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2896%2990103-4

10.1016/S0009-9236(96)90103-4

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8612379%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

1 reference